Anticoagulants and antiplatelet. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy2

Blood Platelets Endothelium, Vascular

Organisms6

Sea Cucumbers Seaweed Rabbits Phaeophyta Ancylostoma Strongylida

Diseases62

Hemorrhage Thrombosis Thromboembolism Stroke Coronary Thrombosis Antiphospholipid Syndrome Thrombophlebitis Acute Coronary Syndrome Venous Thrombosis Thrombophilia Blood Coagulation Disorders Pulmonary Embolism Postoperative Hemorrhage Atrial Fibrillation Venous Thromboembolism Hematoma Recurrence Myocardial Infarction Thrombocytopenia Embolism Cerebral Hemorrhage Activated Protein C Resistance Cerebrovascular Disorders Intracranial Hemorrhages Ischemic Attack, Transient Coronary Artery Disease Protein C Deficiency Brain Ischemia Protein S Deficiency Intracranial Thrombosis Purpura, Thrombocytopenic Antithrombin III Deficiency Carotid Artery Thrombosis Embolism, Cholesterol Coronary Disease Lupus Erythematosus, Systemic Graft Occlusion, Vascular Gastrointestinal Hemorrhage Postoperative Complications Intracranial Embolism and Thrombosis Cardiovascular Diseases Hypoprothrombinemias Blood Loss, Surgical Intracranial Embolism Hemorrhagic Disorders Peripheral Vascular Diseases Coagulation Protein Disorders Oral Hemorrhage Purpura, Thrombocytopenic, Idiopathic Hematoma, Subdural Hematoma, Subdural, Chronic Pregnancy Complications, Hematologic Coronary Restenosis Disseminated Intravascular Coagulation Carotid Artery, Internal, Dissection Acute Disease Angina, Unstable Heart Diseases Arterial Occlusive Diseases Cerebral Infarction Myocardial Ischemia Trigger Finger Disorder

Chemicals and Drugs115

Anticoagulants Platelet Aggregation Inhibitors Ticlopidine Aspirin Warfarin Lupus Coagulation Inhibitor Heparin Acenocoumarol Protein C Phenprocoumon Antithrombins Factor Xa Rodenticides Thiophenes Phenindione 4-Hydroxycoumarins Fibrinolytic Agents Heparin, Low-Molecular-Weight beta-Alanine Protein S Thienopyridines Purinergic P2Y Receptor Antagonists Blood Coagulation Factors Thrombin Thrombomodulin Receptors, Purinergic P2Y12 Vitamin K Prothrombin Dipyridamole Antithrombin III Hirudins Platelet Glycoprotein GPIIb-IIIa Complex Antibodies, Antiphospholipid Antibodies, Anticardiolipin Thromboplastin Enoxaparin Heparin Antagonists Pyridones Factor X Factor V Coagulants beta 2-Glycoprotein I Dicumarol Factor Va Pipecolic Acids Benzimidazoles Tetrazoles Thromboxane B2 Adenosine Diphosphate Vitamin K Epoxide Reductases Phosphodiesterase 3 Inhibitors Dermatan Sulfate Heparin Cofactor II Immunoglobulin Fab Fragments Hemostatics Purinergic P2 Receptor Antagonists Fibrinogen Cardiolipins Sulfinpyrazone Receptor, PAR-1 Fibrin Pyridines Aryl Hydrocarbon Hydroxylases Dalteparin Piperazines Coumarins Autoantibodies Polysaccharides Arthropod Proteins P-Selectin Phenazopyridine Antithrombin Proteins Salivary Proteins and Peptides Thromboxanes Factor VIIa Recombinant Proteins Receptors, Thrombin Platelet Membrane Glycoproteins Factor VIIIa Fibrinopeptide A Citric Acid Cardiovascular Agents Drugs, Investigational Factor VII Antifibrinolytic Agents Fibrin Fibrinogen Degradation Products Morpholines Heparinoids Citrates Heparitin Sulfate Dilazep Phospholipids Ancrod Drug Combinations Antibodies, Monoclonal Chromogenic Compounds Protein C Inhibitor Serine Proteinase Inhibitors Anti-Inflammatory Agents, Non-Steroidal Glycoproteins Tissue Plasminogen Activator Azetidines Edetic Acid Collagen Thromboxane A2 Salicylates Pyrazoles Sirolimus von Willebrand Factor Factor IX Heparin Lyase Benzylamines Factor IXa Tablets, Enteric-Coated Proton Pump Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment45

Prothrombin Time Partial Thromboplastin Time Platelet Function Tests Blood Coagulation Tests International Normalized Ratio Drug Therapy, Combination Thrombin Time Administration, Oral Treatment Outcome Bleeding Time Stents Risk Factors Angioplasty, Balloon, Coronary Platelet Count Perioperative Care Prospective Studies Drug-Eluting Stents Follow-Up Studies Drug Monitoring Randomized Controlled Trials as Topic Risk Assessment Retrospective Studies Thrombelastography Whole Blood Coagulation Time Thrombolytic Therapy Drug Administration Schedule Clinical Trials as Topic Incidence Percutaneous Coronary Intervention Heart Valve Prosthesis Double-Blind Method Hirudin Therapy Registries Blood Preservation Premedication Withholding Treatment Blood Specimen Collection Coronary Angiography Hemostatic Techniques Prosthesis Design Risk Tomography, X-Ray Computed Perioperative Period Cohort Studies Postoperative Care

Phenomena and Processes19

Blood Coagulation Platelet Aggregation Prothrombin Time Partial Thromboplastin Time Thrombin Time Platelet Activation Bleeding Time Time Factors Hemostasis Platelet Count Dose-Response Relationship, Drug Drug Resistance Drug Interactions Whole Blood Coagulation Time Fibrinolysis Platelet Adhesiveness Herb-Drug Interactions Risk Kinetics

Disciplines and Occupations2

Evidence-Based Medicine Pharmacogenetics

Information Science2

Incidence Registries

Health Care24

Treatment Outcome Risk Factors Perioperative Care Prospective Studies Follow-Up Studies Secondary Prevention Randomized Controlled Trials as Topic Risk Assessment Retrospective Studies Rodent Control Clinical Trials as Topic Practice Guidelines as Topic Incidence Double-Blind Method Point-of-Care Systems Registries Withholding Treatment Risk Physician's Practice Patterns Perioperative Period Cohort Studies Societies, Medical Drug Utilization Postoperative Care

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Anticoagulants Platelet Aggregation Inhibitors Ticlopidine Aspirin Warfarin Lupus Coagulation Inhibitor Hemorrhage Thrombosis Blood Coagulation Platelet Aggregation Prothrombin Time Heparin Acenocoumarol Protein C Partial Thromboplastin Time Platelet Function Tests Phenprocoumon Antithrombins Thromboembolism Factor Xa Rodenticides Blood Coagulation Tests Blood Platelets International Normalized Ratio Thiophenes Phenindione 4-Hydroxycoumarins Fibrinolytic Agents Drug Therapy, Combination Thrombin Time Heparin, Low-Molecular-Weight beta-Alanine Protein S Thienopyridines Purinergic P2Y Receptor Antagonists Blood Coagulation Factors Thrombin Platelet Activation Thrombomodulin Receptors, Purinergic P2Y12 Vitamin K Administration, Oral Stroke Coronary Thrombosis Treatment Outcome Prothrombin Antiphospholipid Syndrome Dipyridamole Thrombophlebitis Acute Coronary Syndrome Bleeding Time Antithrombin III Venous Thrombosis Stents Hirudins Thrombophilia Blood Coagulation Disorders Platelet Glycoprotein GPIIb-IIIa Complex Antibodies, Antiphospholipid Risk Factors Pulmonary Embolism Postoperative Hemorrhage Atrial Fibrillation Angioplasty, Balloon, Coronary Time Factors Antibodies, Anticardiolipin Venous Thromboembolism Hemostasis Thromboplastin Hematoma Platelet Count Perioperative Care Enoxaparin Recurrence Myocardial Infarction Prospective Studies Heparin Antagonists Pyridones Thrombocytopenia Factor X Embolism Drug-Eluting Stents Factor V Follow-Up Studies Cerebral Hemorrhage Secondary Prevention Drug Monitoring Coagulants beta 2-Glycoprotein I Dicumarol Activated Protein C Resistance Randomized Controlled Trials as Topic Factor Va Risk Assessment Retrospective Studies Rodent Control Pipecolic Acids Cerebrovascular Disorders Dose-Response Relationship, Drug Intracranial Hemorrhages

No FAQ available that match "anticoagulants and antiplatelet"